CIK 0000818686 · Large accelerated filer
TEVA PHARMACEUTICAL INDUSTRIES LTD
Sign in to watch- Ticker
- TEVA
- Exchange
- NYSE
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- Israel
- Entity type
- operating
- Phone
- 972 (3) 914-8213
- Business address
- TEVA PHARMACEUTICAL INDUSTRIES LIMITED, 124 DVORA HANEVI'A ST., TEL AVIV, Israel
- Former names
- TEVA PHARMACEUTICAL INDUSTRIES LIMITED
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $33,923,078
- in 11 filings, $11.2M under 10b5-1 plans
Net −$33,923,078. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 52 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2026-03-03 | Francis Richard D President and CEO | Sale 10b5-1 | −30,903 | $32.36 | $1.0M | 642,099 |
| 2026-03-03 | Francis Richard D President and CEO | Option exercise 10b5-1 | +891,315 | 1,533,414 | ||
| 2026-03-03 | Francis Richard D President and CEO | Sale 10b5-1 | −412,032 | $32.36 | $13.3M | 1,121,382 |
| 2026-03-03 | Francis Richard D President and CEO | Option exercise · Restricted Share Units 10b5-1 | −67,231 | 67,231 | ||
| 2026-03-03 | Francis Richard D President and CEO | Option exercise · Restricted Share Units 10b5-1 | −891,315 | 0 | ||
| 2026-03-03 | Kalif Eliyahu Sharon EVP, Chief Financial Officer | Option exercise | +49,800 | 107,278 | ||
| 2026-03-03 | Kalif Eliyahu Sharon EVP, Chief Financial Officer | Option exercise | +141,478 | 248,756 | ||
| 2026-03-03 | Kalif Eliyahu Sharon EVP, Chief Financial Officer | Option exercise · Restricted Share Units | −49,800 | 49,802 | ||
| 2026-03-03 | Kalif Eliyahu Sharon EVP, Chief Financial Officer | Option exercise · Restricted Share Units | −141,478 | 0 | ||
| 2026-03-03 | Hughes Eric A See "Remarks" | Option exercise 10b5-1 | +24,900 | 24,900 | ||
| 2026-03-03 | Hughes Eric A See "Remarks" | Sale 10b5-1 | −12,077 | $32.36 | $391K | 12,823 |
| 2026-03-03 | Hughes Eric A See "Remarks" | Option exercise 10b5-1 | +141,478 | 154,301 | ||
| 2026-03-03 | Hughes Eric A See "Remarks" | Sale 10b5-1 | −68,685 | $32.36 | $2.2M | 85,616 |
| 2026-03-03 | Hughes Eric A See "Remarks" | Option exercise · Restricted Share Units 10b5-1 | −24,900 | 24,901 | ||
| 2026-03-03 | Hughes Eric A See "Remarks" | Option exercise · Restricted Share Units 10b5-1 | −141,478 | 0 | ||
| 2026-02-26 | Kalif Eliyahu Sharon EVP, Chief Financial Officer | Sale 10b5-1 | −345,810 | $33.64 | $11.6M | 57,478 |
| 2026-02-15 | Francis Richard D President and CEO | Option exercise 10b5-1 | +161,656 | 433,439 | ||
| 2026-02-15 | Francis Richard D President and CEO | Sale 10b5-1 | −161,656 | $34.22 | $5.5M | 271,783 |
| 2026-02-15 | Francis Richard D President and CEO | Option exercise 10b5-1 | +620,110 | 891,893 | ||
| 2026-02-15 | Francis Richard D President and CEO | Sale 10b5-1 | −286,122 | $34.22 | $9.8M | 605,771 |
Page 10 of 70 · 1,397 trades